Home › Compare › IMHC vs GBDC

IMHC vs GBDC: Dividend Comparison 2026

IMHC yields 18181.82% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IMHC wins by $20382968138483965952.00M in total portfolio value
10 years
IMHC
IMHC
● Live price
18181.82%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20382968138483965952.00M
Annual income
$20,164,798,479,641,134,000,000,000.00
Full IMHC calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — IMHC vs GBDC

📍 IMHC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMHCGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMHC + GBDC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IMHC pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMHC
Annual income on $10K today (after 15% tax)
$1,545,454.55/yr
After 10yr DRIP, annual income (after tax)
$17,140,078,707,694,964,000,000,000.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, IMHC beats the other by $17,140,078,707,694,964,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMHC + GBDC for your $10,000?

IMHC: 50%GBDC: 50%
100% GBDC50/50100% IMHC
Portfolio after 10yr
$10191484069241982976.00M
Annual income
$10,082,399,239,820,567,000,000,000.00/yr
Blended yield
98.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

IMHC
No analyst data
Altman Z
728.1
Piotroski
4/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMHC buys
0
GBDC buys
0
No recent congressional trades found for IMHC or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMHCGBDC
Forward yield18181.82% ✓11.86%
Annual dividend / share$2.00 ✓$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1% ✓
Portfolio after 10y$20382968138483965952.00M ✓$20.85M
Annual income after 10y$20,164,798,479,641,134,000,000,000.00 ✓$16,450,733.83
Total dividends collected$20368560651224936448.00M ✓$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: IMHC vs GBDC ($10,000, DRIP)

YearIMHC PortfolioIMHC Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$1,828,882$1,818,181.82$12,492$1,791.70+$1.82M → IMHC
2$312,726,966$310,770,062.56$16,527$3,160.58+$312.71M → IMHC
3$49,997,862,140$49,663,244,286.24$23,588$5,904.90+$49997.84M → IMHC
4$7,474,070,205,933$7,420,572,493,443.65$37,141$11,901.65+$7474070.17M → IMHC
5$1,044,712,232,322,833$1,036,714,977,202,484.10$66,205$26,463.38+$1044712232.26M → IMHC
6$136,547,911,758,351,100$135,430,069,669,765,680.00$137,452$66,612.65+$136547911758.21M → IMHC
7$16,689,313,388,956,088,000$16,543,207,123,374,653,000.00$342,372$195,298.53+$16689313388955.75M → IMHC
8$1,907,542,220,817,720,100,000$1,889,684,655,491,537,200,000.00$1,053,292$686,954.33+$1907542220817719.00M → IMHC
9$203,896,877,423,206,970,000,000$201,855,807,246,932,000,000,000.00$4,111,439$2,984,416.95+$203896877423206976.00M → IMHC
10$20,382,968,138,483,967,000,000,000$20,164,798,479,641,134,000,000,000.00$20,849,974$16,450,733.83+$20382968138483965952.00M → IMHC

IMHC vs GBDC: Complete Analysis 2026

IMHC — Stock

Imperalis Holding Corp. does not have significant operations. Previously, the company, through its subsidiary, CannaCure Sciences, Inc., engaged in the development, marketing, and sale of cannabidiol (CBD)-based personal care and cosmetic products. The company was formerly known as Coloured (US) Inc. and changed its name to Imperalis Holding Corp. in March 2011. The company was incorporated in 2005 and is headquartered in Las Vegas, Nevada. Imperalis Holding Corp. is a subsidiary of BitNile, Inc.

Full IMHC Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this IMHC vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMHC vs SCHDIMHC vs JEPIIMHC vs OIMHC vs KOIMHC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.